PIMA513275
CA19-9 Monoclonal Antibody (121SLE), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA513275-Each-of-1 | In Stock | ₹ 41,830.00 |
PIMA513275 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 41,830.00
GST (18%): ₹ 7,529.40
Total Price: ₹ 49,359.40
Antigen
CA19-9
Classification
Monoclonal
Concentration
0.2 mg/mL
Formulation
PBS with 0.2% BSA and 0.09% sodium azide; pH 7.4
Host Species
Mouse
Purification Method
Ammonium sulfate precipitation
Regulatory Status
RUO
Target Species
Human
Product Type
Antibody
Isotype
IgM
Applications
Immunohistochemistry (Paraffin)
Clone
121SLE
Conjugate
Unconjugated
Gene Alias
CA19 9; CA19.9; CA-19.9
Immunogen
Mucins from ovarian cyst
Quantity
500 μL
Primary or Secondary
Primary
Content And Storage
4° C
Form
Liquid
Related Products
Description
- MA5-13275 targets CA19-9 in IHC (P) applications and shows reactivity with Human samples
- The MA5-13275 immunogen is mucins from ovarian cyst
- Mucin glycoprotein is a Sialyl Lewis A structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewis A and/or Lewis B blood group antigens
- In normal tissues, sialyl Lewis A antigen is present in ductal epithelium of the breast, kidney, salivary gland, and sweat glands
- Its expression is greatly enhanced in serum as well as in the majority of tumor cells in gastrointestinal (GI) carcinomas, including adenocarcinomas of the stomach, intestine, and pancreas
- Preoperative elevated CA19-9 levels in patients with stage I pancreatic carcinoma decrease to normal values following surgery
- When used serially, CA19-9 can predict recurrence of disease prior to radiographic or clinical findings.